Literature DB >> 435365

Changes in nerve conduction velocity in the mouse after acute and chronic administration of nitroimidazoles.

D G Hirst, B Vojnovic, B Hobson.   

Abstract

The effect of the nitroimidazoles misonidazole, Ro-05-9963, RGW-608 and metronidazole on nerve conduction velocity (NCV) were measured in the anaesthetized mouse. The compounds were administered by i.p. injection either as a single dose of 1 mg/g (only 0.5 mg/g for RGW-608) or in 36 fractions of 0.15 mg/g over 18 days (only 4 fractions in 2 days for RGW-608). After single doses a reduction in nerve conduction velocity was seen with all the compounds except metronidazole, which had no significant effect. During chronic exposure, a reduction in NCV occurred towards the end of the course of injections. All compounds produced an effect, although RGW-608 was the most neurotoxic, giving the largest reduction in NCV after only 4 injections. After the end of chronic exposure to misonidazole, Ro-05-9963 and metronidazole, recovery to normal took 2-3 weeks.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 435365      PMCID: PMC2009849          DOI: 10.1038/bjc.1979.26

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Preliminary neurological evaluation of generalized weakness in zinc pyrithione-treated rats.

Authors:  D R Snyder; E J Gralla; G L Coleman
Journal:  Food Cosmet Toxicol       Date:  1977-02

2.  Further clinical experiences of a phase I study with the hypoxic cell radiosensitizer misonidazole.

Authors:  H D Kogelnik; J H Meyer; K Jentzsch; T Szepesi; K H Kärcher; E Maida; B Mamoli; P Wessely; F Zaunbauer
Journal:  Br J Cancer Suppl       Date:  1978-06

3.  Peripheral neuropathy related to misonidazole: incidence and pathology.

Authors:  R C Urtasun; J D Chapman; M L Feldstein; R P Band; H R Rabin; A F Wilson; B Marynowski; E Starreveld; T Shnitka
Journal:  Br J Cancer Suppl       Date:  1978-06

4.  Hypoxic cell sensitization by misonidazole in vivo and in vitro.

Authors:  N J McNally; J Denekamp; P W Sheldon; I R Flockhart
Journal:  Br J Radiol       Date:  1978-04       Impact factor: 3.039

5.  Prolonged metronidazole administration with protracted radiotherapy: a pilot study on response of advanced tumours.

Authors:  A B Karim
Journal:  Br J Cancer Suppl       Date:  1978-06

6.  Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.

Authors:  I R Flockhart; P Large; D Troup; S L Malcolm; T R Marten
Journal:  Xenobiotica       Date:  1978-02       Impact factor: 1.908

7.  Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative.

Authors:  R C Urtasun; P Band; J D Chapman; H R Rabin; A F Wilson; C G Fryer
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

8.  Mammalian cell toxicity of nitro compounds : dependence upon reduction potential.

Authors:  G E Adams; E D Clarke; R S Jacobs; I J Stratford; R G Wallace; P Wardman; M E Watts
Journal:  Biochem Biophys Res Commun       Date:  1976-10-04       Impact factor: 3.575

9.  Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

Authors:  S Dische; M I Saunders; M E Lee; G E Adams; I R Flockhart
Journal:  Br J Cancer       Date:  1977-05       Impact factor: 7.640

10.  The effect of the radiosensitizer misonidazole on motor nerve conduction velocity in the mouse.

Authors:  D G Hirst; B Vojnovic; I J Stratford; E L Travis
Journal:  Br J Cancer Suppl       Date:  1978-06
View more
  5 in total

1.  Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials.

Authors:  M S Edwards; S K Powers; R A Baringer; D L Jewett; C Bolger; T L Phillips
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

2.  A biochemical method for assessing the neurotoxic effects of misonidazole in the rat.

Authors:  G P Rose; A J Dewar; I J Stratford
Journal:  Br J Cancer       Date:  1980-12       Impact factor: 7.640

3.  Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice.

Authors:  P J Conroy; R Von Burg; D P Penney; W Passalacqua; R M Sutherland
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

4.  Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.

Authors:  C Clarke; K B Dawson; P W Sheldon
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

5.  In vivo assessment of basic 2-nitroimidazole radiosensitizers.

Authors:  M V Williams; J Denekamp; A I Minchinton; M R Stratford
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.